ESCAPE: An Open-Label Trial of Personalized Immunotherapy in Critically lll COVID-19 Patients
Publication year
2022Source
Journal of Innate Immunity, 14, 3, (2022), pp. 218-228ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Internal Medicine
Journal title
Journal of Innate Immunity
Volume
vol. 14
Issue
iss. 3
Page start
p. 218
Page end
p. 228
Subject
All institutes and research themes of the Radboud University Medical Center; Radboudumc 4: lnfectious Diseases and Global Health RIMLS: Radboud Institute for Molecular Life SciencesThis item appears in the following Collection(s)
- Academic publications [229074]
- Electronic publications [111477]
- Faculty of Medical Sciences [87745]
- Open Access publications [80295]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.